Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Green tea is a popular weight-loss drink, but timing matters. Expert reveals the best times to drink it for fat burning, ...

participants who lifted weights first experienced significantly greater reductions in visceral fat, linked to cardiovascular ...

New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...

Following the completion of its offering of common stock, the Company now has 62,436,670 shares of common stock outstanding. Additionally, the Company will have full availability of $5.0 million under ...

Doctors explain if Berberine, dubbed “Nature’s Ozempic,” can really help with menopause weight loss. Here’s what to know.

The phone in every pocket can become the most scalable care channel we’ve ever had, but only if we build for trust, ...

This bestselling suncream is perfect for wearing under makeup and is highly recommended by beauty experts.

Weight loss jabs could impact your contraception. Here’s why - ANALYSIS: Simon Cork on the surprising side effect of weight ...

U.S. drugmaker Eli Lilly said on Monday it will offer the higher dose versions of its popular weight-loss drug Zepbound on ...

Turning 40 doesn’t mean slowing down, it means training smarter. Experts reveal gender-specific fitness rules to boost ...

Part of the appeal of amylin analogs is the potential to drive weight loss without causing the same level of tolerability problems as GLP-1 receptor agonists. Lilly reported relatively low rates of ...